» Articles » PMID: 19177154

For Estimating Creatinine Clearance Measuring Muscle Mass Gives Better Results Than Those Based on Demographics

Overview
Journal Kidney Int
Publisher Elsevier
Specialty Nephrology
Date 2009 Jan 30
PMID 19177154
Citations 59
Authors
Affiliations
Soon will be listed here.
Abstract

Estimation of creatinine clearance requires knowledge of creatinine generation which can vary in different groups of patients. Since the main source of creatinine is muscle we used dual-energy X-ray absorptiometry to measure the mass of muscle in a cohort of adult men and women in Rochester, Minnesota. Serum and 24 h urinary creatinines were measured directly. The urinary creatinine was estimated using equations based on age and gender and muscle mass in order to calculate creatinine clearance. Among 664 subjects with a mean age of 55+/-20 years, 51% of whom were women, the model fit for urinary creatinine estimated with age and gender (R2=0.359) was similar to that estimated with measured muscle mass (R2=0.359). The likelihood of chronic kidney disease (creatinine clearance of less than 60 ml/min per 1.73 m2) in older subjects was highest with equations that used age, and likelihood of CKD in women was highest with equations that used gender. The outcomes of mortality and cardiovascular disease had stronger associations with decreased creatinine clearance calculated with age and gender than by the clearance calculated with muscle mass. This could be explained by age being a potent predictor of mortality and cardiovascular disease independent of urinary creatinine, muscle mass, and gender. Our study shows that the likelihood of chronic kidney disease in the elderly and in women and the risk of adverse outcomes may be inflated by equations that use patient demographics to estimate creatinine generation.

Citing Articles

Association between phase angle and daily creatinine excretion changes in critically ill patients: an approach to muscle mass.

Vargas-Errazuriz P, Dreyse N, Lopez R, Cano-Cappellacci M, Graf J, Guerrero J Front Physiol. 2025; 15():1508709.

PMID: 39844897 PMC: 11753204. DOI: 10.3389/fphys.2024.1508709.


Measuring Albuminuria in Individuals With Obesity: Pitfalls of the Urinary Albumin-Creatinine Ratio.

Chagnac A, Friedman A Kidney Med. 2024; 6(4):100804.

PMID: 38576526 PMC: 10993191. DOI: 10.1016/j.xkme.2024.100804.


Association of organ damage with predicted fat mass in a community-dwelling elderly: the Northern Shanghai study.

Xu C, Yu S, Zhao S, Chi C, Fan X, Teliewubai J Aging Clin Exp Res. 2024; 36(1):35.

PMID: 38345775 PMC: 10861618. DOI: 10.1007/s40520-023-02658-7.


Creatinine-cystatin C ratio and death with a functioning graft in kidney transplant recipients.

Choi M, Kim D, Yim S, Kim H, Kim H, Yang J Sci Rep. 2024; 14(1):1966.

PMID: 38263396 PMC: 10806062. DOI: 10.1038/s41598-024-52649-5.


Differences in the epidemiology, management and outcomes of kidney disease in men and women.

Chesnaye N, Carrero J, Hecking M, Jager K Nat Rev Nephrol. 2023; 20(1):7-20.

PMID: 37985869 DOI: 10.1038/s41581-023-00784-z.


References
1.
Verhave J, Gansevoort R, Hillege H, de Zeeuw D, Curhan G, de Jong P . Drawbacks of the use of indirect estimates of renal function to evaluate the effect of risk factors on renal function. J Am Soc Nephrol. 2004; 15(5):1316-22. View

2.
Levey A, Eckardt K, Tsukamoto Y, Levin A, Coresh J, Rossert J . Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005; 67(6):2089-100. DOI: 10.1111/j.1523-1755.2005.00365.x. View

3.
Go A, Chertow G, Fan D, McCulloch C, Hsu C . Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004; 351(13):1296-305. DOI: 10.1056/NEJMoa041031. View

4.
Morley J . Diabetes, sarcopenia, and frailty. Clin Geriatr Med. 2008; 24(3):455-69, vi. DOI: 10.1016/j.cger.2008.03.004. View

5.
Melton 3rd L . History of the Rochester Epidemiology Project. Mayo Clin Proc. 1996; 71(3):266-74. DOI: 10.4065/71.3.266. View